Home / Emtricitabine, Tenofovir Disoproxil and Efavirenz / New Zealand
NZ ATC J05AR06 · updated 2 Nov 2026
Emtricitabine, Tenofovir Disoproxil and Efavirenz shortage in New Zealand
Is there an Emtricitabine, Tenofovir Disoproxil and Efavirenz shortage in New Zealand?
Yes. As of 2 Nov 2026, 1 Emtricitabine, Tenofovir Disoproxil and Efavirenz product is reported short in New Zealand, the first since 17 Jan 2025. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Belgium. All countries.
Affected products in New Zealand
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NZ | Efavirenz with emtricitabine and tenofovir disoproxil (Viatris) | Viatris | 17 Jan 2025 | not given | Not stated |
Source
Pharmac (Pharmaceutical Management Agency), medicine notices. Official list. Supply issues and discontinuations of funded medicines that Pharmac has notified; one row per notice.